TY  - JOUR
AU  - Ong, Kevin T
PY  - 2018
DA  - 2018/09/03
TI  - Neuroimaging in Dementia
JO  - OBM Geriatrics
SP  - 011
VL  - 02
IS  - 03
AB  - Amyloid positron emission tomography (PET), fluorodeoxyglucose (FDG) PET, and magnetic resonance imaging (MRI) are three modalities in the imaging of Alzheimer’s disease (AD). This article reviews the experience and data obtained from AD research using these techniques to understand the natural history of AD and to enhance therapeutic trials. It is now realised that their use can improve early detection of AD, and has opened a new corridor which may lead toward successful treatment.
SN  - 2638-1311
UR  - https://doi.org/10.21926/obm.geriatr.1803011
DO  - 10.21926/obm.geriatr.1803011
ID  - Ong2018
ER  -